Français
6. Conclusion
Industrial processes for culturing animal cells to produce therapeutic molecules are currently booming, particularly in the recombinant antibody and vaccine sectors. In addition to a strict regulatory framework, these processes are characterized by specific features such as nutritional requirements imposing a complex formulation of culture media, high cell sensitivity to their physico-chemical environment (pH, temperature, stress, etc.), and delicate operation. As a result, there is still considerable scope for improving their performance, notably through research into new cell lines, the use of better-controlled culture media, a better understanding of cell metabolism, the expert application of PAT methods or the fine modeling of transport phenomena in the bioreactor.
The Ultimate Scientific and Technical Reference
This article is included in
Healthcare technologies
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Conclusion
Bibliography
Websites
LEEM study. Bioproduction in 2008: state of play and recommendations for French attractiveness. http://www.leem.org/dossier/101/etude-bioproduction-en-2008-etat-des-lieux-et-recommandations-pour-l-attractivite-1297.htm
Events (non-exhaustive list)
ESACT Congress, held every two years in Europe http://www.esact.org/meetings_esact.html
Congress of the engineering foundation: cell culture engineering, held every two years, mainly in the U.S.
Directory
Organizations – Federations – Associations (non-exhaustive list)
ESACT Association: European Society of Animal Cell Technology http://www.esact.org/
Association ACTIP: Animal Cell Technology Industrial Platform http://www.actip.org/
Training courses...
The Ultimate Scientific and Technical Reference
